Object: to provide a novel prostaglandin E1 which is excellent in drug efficacy while reduced in adverse reactions as compared with conventional ones. Constitution: a PGE1 analogue represented by general formula (I) and its salt, wherein A represents vinylene or ethynylene; R<1> represents hydrogen, C1 to C6 alkyl or aryl; and R<2> represents C5 to C10 branched aliphatic hydrocarbyl.
申请公布号
WO9218472(A1)
申请公布日期
1992.10.29
申请号
WO1992JP00513
申请日期
1992.04.21
申请人
TAISHO PHARMACEUTICAL CO., LTD.;SATO, FUMIE
发明人
SATO, FUMIE;AMANO, TAKEHIRO;KAMEO, KAZUYA;TANAMI, TOHRU;MUTOH, MASARU;ONO, NAOYA;GOTO, JUN